{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:43:10Z","timestamp":1790170990685,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.2119\/molmed.2017.00012","type":"journal-article","created":{"date-parts":[[2017,9,30]],"date-time":"2017-09-30T06:06:29Z","timestamp":1506751589000},"page":"196-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["The Histone Methyltransferase Mixed Lineage Leukemia (MLL) 3 May Play a Potential Role in Clinical Dilated Cardiomyopathy"],"prefix":"10.1186","volume":"23","author":[{"given":"Ding-Sheng","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Shu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Lai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Hai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,9]]},"reference":[{"key":"2301196_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","volume":"10","author":"RE Hershberger","year":"2013","unstructured":"Hershberger RE, Hedges DJ, Morales A. (2013) Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat. Rev. Cardiol. 10:531\u201347.","journal-title":"Nat. Rev. Cardiol."},{"key":"2301196_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1101\/gad.2018511","volume":"25","author":"AT Nguyen","year":"2011","unstructured":"Nguyen AT, et al. (2011) DOT1L regulates dystrophin expression and is critical for cardiac function. Genes Dev. 25:263\u201374.","journal-title":"Genes Dev."},{"key":"2301196_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ng.1068","volume":"44","author":"P Delgado-Olguin","year":"2012","unstructured":"Delgado-Olguin P, et al. (2012) Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis. Nat. Genet. 44:343\u201347.","journal-title":"Nat. Genet."},{"key":"2301196_CR4","doi-asserted-by":"publisher","first-page":"20395","DOI":"10.1074\/jbc.M701574200","volume":"282","author":"YW Cho","year":"2007","unstructured":"Cho YW, et al. (2007) PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. J. Biol. Chem. 282:20395\u2013406.","journal-title":"J. Biol. Chem."},{"key":"2301196_CR5","doi-asserted-by":"publisher","first-page":"8695","DOI":"10.1073\/pnas.082249499","volume":"99","author":"BE Bernstein","year":"2002","unstructured":"Bernstein BE, et al. (2002) Methylation of histone H3 Lys 4 in coding regions of active genes. Proc. Natl. Acad. Sci. USA. 99:8695\u2013700.","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2301196_CR6","doi-asserted-by":"publisher","first-page":"19229","DOI":"10.1073\/pnas.0810100105","volume":"105","author":"J Lee","year":"2008","unstructured":"Lee J, et al. (2008) Targeted inactivation of MLL3 histone H3-Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis. Proc. Natl. Acad. Sci. USA. 105:19229\u201334.","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2301196_CR7","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1021\/bi102037t","volume":"50","author":"KI Ansari","year":"2011","unstructured":"Ansari KI, Shrestha B, Hussain I, Kasiri S, Mandal SS. (2011) Histone methylases MLL1 and MLL3 coordinate with estrogen receptors in estrogen-mediated HOXB9 expression. Biochemistry. 50:3517\u201327.","journal-title":"Biochemistry"},{"key":"2301196_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13148-015-0075-3","volume":"7","author":"S Weirich","year":"2015","unstructured":"Weirich S, Kudithipudi S, Kycia I, Jeltsch A. (2015) Somatic cancer mutations in the MLL3-SET domain alter the catalytic properties of the enzyme. Clin. Epigenetics. 7:36.","journal-title":"Clin. Epigenetics."},{"key":"2301196_CR9","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1111\/j.1742-4658.2010.07606.x","volume":"277","author":"KI Ansari","year":"2010","unstructured":"Ansari KI, Mandal SS. (2010) Mixed lineage leukemia: roles in gene expression, hormone signaling and mRNA processing. FEBS J. 277: 1790\u20131804.","journal-title":"FEBS J."},{"key":"2301196_CR10","doi-asserted-by":"crossref","unstructured":"Sze CC, Shilatifard A. (2016) MLL3\/MLL4\/COMPASS family on epigenetic regulation of enhancer function and cancer. Cold Spring Harb. Perspect. Med. 6.","DOI":"10.1101\/cshperspect.a026427"},{"key":"2301196_CR11","doi-asserted-by":"publisher","first-page":"8513","DOI":"10.1073\/pnas.0902873106","volume":"106","author":"J Lee","year":"2009","unstructured":"Lee J, et al. (2009) A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4. Proc. Natl. Acad. Sci. USA. 106:8513\u201318.","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2301196_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.gene.2005.11.013","volume":"371","author":"ME Brun","year":"2006","unstructured":"Brun ME, et al. (2006) Characterization and expression analysis during embryo development of the mouse ortholog of MLL3. Gene. 371:25\u201333.","journal-title":"Gene."},{"key":"2301196_CR13","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1182\/blood-2012-12-470559","volume":"121","author":"WD Li","year":"2013","unstructured":"Li WD, et al. (2013) Exome sequencing identifies an MLL3 gene germ line mutation in a pedigree of colorectal cancer and acute myeloid leukemia. Blood. 121:1478\u201379.","journal-title":"Blood"},{"key":"2301196_CR14","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1073\/pnas.1214168110","volume":"110","author":"UK Valekunja","year":"2013","unstructured":"Valekunja UK, et al. (2013) Histone methyltransferase MLL3 contributes to genome-scale circadian transcription. Proc. Natl. Acad. Sci. USA. 110:1554\u201359.","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2301196_CR15","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1242\/dev.132688","volume":"143","author":"SY Ang","year":"2016","unstructured":"Ang SY, et al. (2016) KMT2D regulates specific programs in heart development via histone H3 lysine 4 di-methylation. Development. 143:810\u201321.","journal-title":"Development"},{"key":"2301196_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.5483\/BMBRep.2016.49.7.062","volume":"49","author":"MJ Son","year":"2016","unstructured":"Son MJ, et al. (2016) Methyltransferase and demethylase profiling studies during brown adipocyte differentiation. BMB Reports. 49:388\u201393.","journal-title":"BMB Reports."},{"key":"2301196_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.cancergen.2015.01.005","volume":"208","author":"DJ Ford","year":"2015","unstructured":"Ford DJ, Dingwall AK. (2015) The cancer COMPASS: navigating the functions of MLL complexes in cancer. Cancer Genet. 208:178\u201391.","journal-title":"Cancer Genet."},{"key":"2301196_CR18","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1038\/ncomms4303","volume":"5","author":"DS Jiang","year":"2014","unstructured":"Jiang DS, et al. (2014) IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling. Nat. Commun. 5:3303.","journal-title":"Nat. Commun."},{"key":"2301196_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1161\/HYPERTENSIONAHA.113.01506","volume":"63","author":"DS Jiang","year":"2014","unstructured":"Jiang DS, et al. (2014) Signal regulatory protein-alpha protects against cardiac hypertrophy via the disruption of toll-like receptor 4 signaling. Hypertension. 63:96\u2013104.","journal-title":"Hypertension"},{"key":"2301196_CR20","first-page":"37","volume":"8","author":"DS Jiang","year":"2016","unstructured":"Jiang DS, et al. (2016) The potential role of lysosome-associated membrane protein 3 (LAMP3) on cardiac remodelling. Am. J. Transl. Res. 8:37\u201348.","journal-title":"Am. J. Transl. Res."},{"key":"2301196_CR21","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1161\/HYPERTENSIONAHA.111.00614","volume":"61","author":"DS Jiang","year":"2013","unstructured":"Jiang DS, et al. (2013) Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy. Hypertension. 61:1193\u20131202.","journal-title":"Hypertension"},{"key":"2301196_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1161\/HYPERTENSIONAHA.114.03229","volume":"64","author":"DS Jiang","year":"2014","unstructured":"Jiang DS, et al. (2014) Interferon regulatory factor 1 is required for cardiac remodeling in response to pressure overload. Hypertension. 64:77\u201386.","journal-title":"Hypertension"},{"key":"2301196_CR23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1161\/HYPERTENSIONAHA.113.02653","volume":"63","author":"DS Jiang","year":"2014","unstructured":"Jiang DS, et al. (2014) Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy. Hypertension. 63:713\u201322.","journal-title":"Hypertension"},{"key":"2301196_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1161\/HYPERTENSIONAHA.113.02083","volume":"63","author":"DS Jiang","year":"2014","unstructured":"Jiang DS, et al. (2014) Interferon regulatory factor 9 protects against cardiac hypertrophy by targeting myocardin. Hypertension. 63:119\u201327.","journal-title":"Hypertension"},{"key":"2301196_CR25","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/hep.27578","volume":"61","author":"DH Kim","year":"2015","unstructured":"Kim DH, et al. (2015) Crucial roles of mixed-lineage leukemia 3 and 4 as epigenetic switches of the hepatic circadian clock controlling bile acid homeostasis in mice. Hepatology. 61:1012\u201323.","journal-title":"Hepatology"},{"key":"2301196_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2217\/epi.14.60","volume":"7","author":"Q-J Zhang","year":"2015","unstructured":"Zhang Q-J, Liu Z-P. (2015) Histone methylations in heart development, congenital and adult heart diseases. Epigenomics. 7:321\u201330.","journal-title":"Epigenomics"},{"key":"2301196_CR27","first-page":"2159","volume":"7","author":"X Yi","year":"2015","unstructured":"Yi X, Jiang XJ, Li XY, Jiang DS. (2015) Histone methyltransferases: novel targets for tumor and developmental defects. Am. J. Transl. Res. 7:2159\u201375.","journal-title":"Am. J. Transl. Res."},{"key":"2301196_CR28","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.mod.2013.07.002","volume":"130","author":"M Inagawa","year":"2013","unstructured":"Inagawa M, et al. (2013) Histone H3 lysine 9 methyltransferases, G9a and GLP are essential for cardiac morphogenesis. Mech. Dev. 130:519\u201331.","journal-title":"Mech. Dev."},{"issue":"12","key":"2301196_CR29","doi-asserted-by":"publisher","first-page":"e004076","DOI":"10.1161\/JAHA.116.004076","volume":"5","author":"O Gidlof","year":"2016","unstructured":"Gidlof O, et al. (2016) Ischemic preconditioning confers epigenetic repression of Mtor and induction of autophagy through G9a-dependent H3K9 dimethylation. J. Am. Heart Assoc. 5(12): e004076.","journal-title":"J. Am. Heart Assoc."},{"key":"2301196_CR30","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1016\/j.bbamcr.2014.06.019","volume":"1843","author":"A Sajjad","year":"2014","unstructured":"Sajjad A, et al. (2014) Lysine methyltransferase Smyd2 suppresses p53-dependent cardiomyocyte apoptosis. Biochim. Biophys. Acta. 1843:2556\u201362.","journal-title":"Biochim. Biophys. Acta."},{"key":"2301196_CR31","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1172\/JCI46277","volume":"121","author":"QJ Zhang","year":"2011","unstructured":"Zhang QJ, et al. (2011) The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice. J. Clin. Invest. 121:2447\u201356.","journal-title":"J. Clin. Invest."},{"key":"2301196_CR32","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s12015-014-9527-y","volume":"10","author":"X Wan","year":"2014","unstructured":"Wan X, et al. (2014) Mll2 controls cardiac lineage differentiation of mouse embryonic stem cells by promoting H3K4me3 deposition at cardiac-specific genes. Stem Cell Rev. 10:643\u201352.","journal-title":"Stem Cell Rev."},{"key":"2301196_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.devcel.2011.11.009","volume":"22","author":"S Lee","year":"2012","unstructured":"Lee S, Lee JW, Lee SK. (2012) UTX, a histone H3-lysine 27 demethylase, acts as a critical switch to activate the cardiac developmental program. Dev. Cell. 22:25\u201337.","journal-title":"Dev. Cell."},{"key":"2301196_CR34","doi-asserted-by":"publisher","first-page":"e0162515","DOI":"10.1371\/journal.pone.0162515","volume":"11","author":"DT Starczynowski","year":"2016","unstructured":"Starczynowski DT, Arcipowski KM, Bulic M, Gurbuxani S, Licht JD. (2016) Loss of Mll3 catalytic function promotes aberrant myelopoiesis. PLoS One. 11: e0162515.","journal-title":"PLoS One"},{"key":"2301196_CR35","doi-asserted-by":"publisher","first-page":"15392","DOI":"10.1073\/pnas.0607313103","volume":"103","author":"S Lee","year":"2006","unstructured":"Lee S, et al. (2006) Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. Proc. Natl. Acad. Sci. USA. 103:15392\u201397.","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2301196_CR36","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ccr.2014.03.016","volume":"25","author":"C Chen","year":"2014","unstructured":"Chen C, et al. (2014) MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia. Cancer Cell. 25:652\u201365.","journal-title":"Cancer Cell."},{"key":"2301196_CR37","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s12253-010-9316-0","volume":"17","author":"XX Wang","year":"2011","unstructured":"Wang XX, et al. (2011) Somatic mutations of the mixed-lineage leukemia 3 (MLL3) gene in primary breast cancers. Pathol. Oncol. Res. 17:429\u201333.","journal-title":"Pathol. Oncol. Res."},{"key":"2301196_CR38","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3892\/ijo.2013.1981","volume":"43","author":"A Rabello Ddo","year":"2013","unstructured":"Rabello Ddo A, de Moura CA, de Andrade RV, Motoyama AB, Silva FP. (2013) Altered expression of MLL methyltransferase family genes in breast cancer. Int. J. Oncol. 43:653\u201360.","journal-title":"Int. J. Oncol."},{"key":"2301196_CR39","doi-asserted-by":"publisher","first-page":"7513","DOI":"10.4238\/2014.September.12.18","volume":"13","author":"B Li","year":"2014","unstructured":"Li B, et al. (2014) Association of MLL3 expression with prognosis in gastric cancer. Genet. Mol. Res. 13:7513\u201318.","journal-title":"Genet. Mol. Res."},{"key":"2301196_CR40","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature12634","volume":"502","author":"C Kandoth","year":"2013","unstructured":"Kandoth C, et al. (2013) Mutational landscape and significance across 12 major cancer types. Nature. 502:333\u201339.","journal-title":"Nature"},{"key":"2301196_CR41","doi-asserted-by":"publisher","first-page":"12573","DOI":"10.1073\/pnas.0400752101","volume":"101","author":"AJ Watt","year":"2004","unstructured":"Watt AJ, Battle MA, Li J, Duncan SA. (2004) GATA4 is essential for formation of the proepicardium and regulates cardiogenesis. Proc. Natl. Acad. Sci. USA. 101:12573\u201378.","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2301196_CR42","doi-asserted-by":"publisher","first-page":"14471","DOI":"10.1073\/pnas.0602543103","volume":"103","author":"E Bisping","year":"2006","unstructured":"Bisping E, et al. (2006) Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. Proc. Natl. Acad. Sci. USA. 103:14471\u201376.","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2301196_CR43","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/cvr\/cvt190","volume":"100","author":"SC Hsu","year":"2013","unstructured":"Hsu SC, Chang YT, Chen CC. (2013) Early growth response 1 is an early signal inducing Cav3.2 T-type calcium channels during cardiac hypertrophy. Cardiovasc. Res. 100:222\u201330.","journal-title":"Cardiovasc. Res."},{"key":"2301196_CR44","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1161\/CIRCULATIONAHA.107.704197","volume":"116","author":"M Bujak","year":"2007","unstructured":"Bujak M, et al. (2007) Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation. 116:2127\u201338.","journal-title":"Circulation"},{"key":"2301196_CR45","doi-asserted-by":"publisher","first-page":"H796","DOI":"10.1152\/ajpheart.2000.278.3.H796","volume":"278","author":"N Saadane","year":"2000","unstructured":"Saadane N, Alpert L, Chalifour LE. (2000) Altered molecular response to adrenoreceptor-induced cardiac hypertrophy in Egr-1-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 278:H796\u2013805.","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2301196_CR46","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1161\/HYPERTENSIONAHA.109.147611","volume":"55","author":"XR Huang","year":"2010","unstructured":"Huang XR, et al. (2010) Smad3 mediates cardiac inflammation and fibrosis in angiotensin II-induced hypertensive cardiac remodeling. Hypertension. 55:1165\u201371.","journal-title":"Hypertension"},{"key":"2301196_CR47","doi-asserted-by":"publisher","first-page":"30245","DOI":"10.1074\/jbc.M102174200","volume":"276","author":"Q Liang","year":"2001","unstructured":"Liang Q, et al. (2001) The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J. Biol. Chem. 276:30245\u201353.","journal-title":"J. Biol. Chem."},{"key":"2301196_CR48","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1152\/physiolgenomics.90364.2008","volume":"38","author":"C Cappuzzello","year":"2009","unstructured":"Cappuzzello C, et al. (2009) Gene expression profiles in peripheral blood mononuclear cells of chronic heart failure patients. Physiol. Genomics. 38:233\u201340.","journal-title":"Physiol. Genomics."}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2017.00012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.2119\/molmed.2017.00012\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.molmed.org\/content\/pdfstore\/17_012_Jiang.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2017.00012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T01:40:58Z","timestamp":1554514858000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2017.00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["2301196"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2017.00012","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"17 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}